Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pivotal mental states
Ari Brouwer, Robin Carhart‐Harris
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 319-352
Open Access | Times Cited: 111

Showing 26-50 of 111 citing articles:

High ventilation breathwork practices: An overview of their effects, mechanisms, and considerations for clinical applications
Guy W. Fincham, Amy Kartar, Malin V. Uthaug, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105453-105453
Open Access | Times Cited: 16
Psychedelics and the ‘inner healer’: Myth or mechanism?
Joseph Peill, M. Marguilho, David Erritzøe, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 417-424
Open Access | Times Cited: 7
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach
Phil Wolfson, Gita Vaid
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
On the Varieties of Conscious Experiences: Altered Beliefs Under Psychedelics (ALBUS)
Adam Safron, Arthur Juliani, Nicco Reggente, et al.
(2020)
Closed Access | Times Cited: 41
Psychedelics alter metaphysical beliefs
Christopher Timmermann, Hannes Kettner, Chris Letheby, et al.
(2021)
Open Access | Times Cited: 34
Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being
Valérie Bonnelle, Amanda Feilding, Fernando E. Rosas, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 10, pp. 887-896
Open Access | Times Cited: 4
A qualitative analysis of the psychedelic mushroom come-up and come-down
Ari Brouwer, Joshua K. Brown, Earth Erowid, et al.
npj Mental Health Research (2025) Vol. 4, Iss. 1
Open Access
The road to Aha: A recipe for mental breakthroughs
Kadi Tulver, Karl Kristjan Kaup, Jaan Aru
Cognition (2025) Vol. 257, pp. 106081-106081
Closed Access
On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)
Adam Safron, Arthur Juliani, Nicco Reggente, et al.
Neuroscience of Consciousness (2025) Vol. 2025, Iss. 1
Open Access
Psychedelics and autobiographical memory – six open questions
Samuli Kangaslampi, Morten Peter Lietz
Psychopharmacology (2025)
Open Access
Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution
Charlotte Martial, Géraldine Fontaine, Olivia Gosseries, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 929-929
Open Access | Times Cited: 31
Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis
Haley Maria Dourron, Camilla K. Strauss, Peter S. Hendricks
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 984-1029
Open Access | Times Cited: 21
Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study
Karl Kristjan Kaup, Madis Vasser, Kadi Tulver, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 12
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 11
Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings
Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 3
Catalysts for change: the cellular neurobiology of psychedelics
Matthew I. Banks, Zarmeen Zahid, N. Jones, et al.
Molecular Biology of the Cell (2021) Vol. 32, Iss. 12, pp. 1135-1144
Open Access | Times Cited: 25
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy
Agnieszka D. Sekula, Luke A. Downey, Prashanth Puspanathan
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 16
Psychedelic Psychotherapy: Building Wholeness Through Connection
Gita Vaid, Barry C. Walker
Global Advances in Health and Medicine (2022) Vol. 11, pp. 2164957X2210811-2164957X2210811
Open Access | Times Cited: 16
A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex
Andrea I. Luppi, Manesh Girn, Fernando E. Rosas, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 56-80
Open Access | Times Cited: 10
Transformative Experience
Daniel Villiger
Philosophy Compass (2024) Vol. 19, Iss. 6
Open Access | Times Cited: 3
Psychotomimetic compensation versus sensitization
Ari Brouwer, Robin Carhart‐Harris, Charles L. Raison
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Psychedelics for Brain Injury: A Mini-Review
M. Ijaz Khan, Gregory T. Carter, Sunil Aggarwal, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 22
A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development
Henry J. Whitfield
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 20
A Qualitative Study of Intention and Impact of Ayahuasca Use by Westerners
Geoff J. Bathje, Jon Fenton, Daniel Pillersdorf, et al.
(2021)
Closed Access | Times Cited: 20
Focusing on the negative: cases of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
(2023)
Open Access | Times Cited: 8

Scroll to top